Company intelligence / Profile preview

Spinal Stabilization Technologies

San Antonio, Texas, United Statessstspine.com ↗

Ownership: Private
Development stage: Other

Overview

SST's PerQdisc Nucleus Replacement System has shown strong clinical results in feasibility trials involving over 40 patients, demonstrating significant reduction in pain and improved outcomes. The device is currently being evaluated in a U.S. IDE trial after receiving FDA Breakthrough Device designation. Early data suggest the procedure is minimally invasive, preserves spinal motion, and allows for rapid recovery compared to traditional fusion or total disc replacement surgeries.

Therapeutic areas: RheumatologyNeurology
Modalities: DeviceSilicone-based prosthesis (for nucleus pulposus replacement)
Industry: Implantable Medical Devices

Partnerships

Clinical partnerships with leading spine surgeons and hospitals for IDE trials

Beyond the preview

Go deeper on Spinal Stabilization Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spinal Stabilization Technologies.

Explore the full profile